Aqua Bio Technology ASA

BST:3FZ Stock Report

Market Cap: €16.6m

Aqua Bio Technology Valuation

Is 3FZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 3FZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 3FZ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 3FZ's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3FZ?

Key metric: As 3FZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 3FZ. This is calculated by dividing 3FZ's market cap by their current revenue.
What is 3FZ's PS Ratio?
PS Ratio14x
SalesNOK 13.82m
Market CapNOK 193.19m

Price to Sales Ratio vs Peers

How does 3FZ's PS Ratio compare to its peers?

The above table shows the PS ratio for 3FZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
BIG1 Bio-Gate
0.9x16.3%€6.5m
BNN BRAIN Biotech
1.3x8.5%€71.4m
NTG Nabaltec
0.6x5.0%€123.2m
2HRA H&R GmbH KGaA
0.1x3.0%€129.2m
3FZ Aqua Bio Technology
14xn/a€193.2m

Price-To-Sales vs Peers: 3FZ is expensive based on its Price-To-Sales Ratio (14x) compared to the peer average (0.7x).

Price to Sales Ratio vs Industry

How does 3FZ's PS Ratio compare vs other companies in the European Chemicals Industry?

27 CompaniesPrice / SalesEstimated GrowthMarket Cap
3FZ 14.0xIndustry Avg. 1.0xNo. of Companies30PS01.22.43.64.86+
27 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 3FZ is expensive based on its Price-To-Sales Ratio (14x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is 3FZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3FZ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio14x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 3FZ's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Central Asia Metals

UK£283.6m

Operates as a base metals producer.

9C3

UK£1.91

7D

2.7%

1Y

2.1%

Cabka

€62.8m

Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.

7GW

€2.48

7D

0%

1Y

-59.9%

African Rainbow Minerals

R31.4b

Through its subsidiaries, operates as a diversified mining and minerals company in South Africa, Malaysia, and Switzerland.

EB9

R8.30

7D

-1.2%

1Y

-6.2%